Zmat3 Is a Key Splicing Regulator in the p53 Tumor Suppression ProgramKathryn Bieging-Rolett, Laura D. Attardi|Molecular Cell|2020Cited by 119
1327 Novel GCN2 modulator HC-7366 decreases pulmonary metastases and reduces myeloid-derived suppressor cellsJeremy Drees, Nandita Bose, Sho Fujisawa et al.|Regular and Young Investigator Award Abstracts|2022Cited by 5
Abstract 6231: Activation of GCN2 by HC-7366 results in significant antitumor efficacy as monotherapy and in combination with multiple standard of care agents in various solid cancer modelsFeven Tameire, Nandita Bose, Paulina M. Wojnarowicz et al.|Cancer Research|2023Cited by 3
Activation of GCN2 By HC-7366 Results in Significant Anti-Tumor Efficacy As Monotherapy and Overcomes Resistance Mechanisms When Combined with Venetoclax in AMLFeven Tameire, Nandita Bose, Nicholas Collette et al.|Blood|2023Cited by 3